Literature DB >> 7691699

Distant metastasis of hepatocellular carcinoma after successful treatment of the primary lesion.

Y Inagaki1, M Unoura, T Urabe, H Ogino, S Terasaki, E Matsushita, S Kaneko, T Morioka, A Furusawa, T Wakabayashi.   

Abstract

Recent advances in both diagnosis and treatment of hepatocellular carcinoma (HCC) have improved the prognosis and changed the clinical significance of the subsequently increasing distant metastases. Of 163 patients with HCC, 76 (47%) were treated successfully. The cumulative recurrence rate in these patients was 65% after 3 years, and 82% after 5 years. Six patients with HCC in whom distant metastases were detected after successful treatment of the primary lesion, are reported. Two patients underwent curative surgical resection, and four cases were treated medically, resulting in a 31.9 to 94.3% reduction in tumor size in the CT scan image. Distant metastases without intrahepatic recurrence were diagnosed 10 to 46 months after the treatment of the primary lesions. The sites of the metastases included bone 3; lung 2; and adrenal gland 1. Distant metastases found after successful treatment of the primary lesions are of great clinical significance for the treatment of HCC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691699

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis.

Authors:  Ae Lyoung Min; Jong Young Choi; Hyun Young Woo; Jin Dong Kim; Jung Hyun Kwon; Si Hyun Bae; Seung Kew Yoon; Seung Hun Shin; Yeun Jun Chung; Chan Kwon Jung
Journal:  Clin Exp Metastasis       Date:  2009-06-16       Impact factor: 5.150

2.  Muscle metastasis from hepatocellular carcinoma in a patient treated with TACE.

Authors:  D Sirigu; L Loi; R Mura; V Migaleddu; G Campisi
Journal:  J Ultrasound       Date:  2009-02-20

3.  Long-term survival after report resection of pulmonary metastases from hepatocellular carcinoma: report of two cases.

Authors:  Toru Nakamura; Taizo Kimura; Yasuhiko Umehara; Kenji Suzuki; Kazuya Okamoto; Takuya Okumura; Sei Morizumi; Toshiki Kawabata; Akira Komiyama
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Adrenalectomy for metastases from hepatocellular carcinoma - a single center experience.

Authors:  Irinel Popescu; Sorin Alexandrescu; Silviu Ciurea; Vlad Brasoveanu; Doina Hrehoret; Eliza Gangone; Mirela Boros; Vlad Herlea; Adina Croitoru
Journal:  Langenbecks Arch Surg       Date:  2006-12-23       Impact factor: 3.445

5.  Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.

Authors:  Kiminori Uka; Hiroshi Aikata; Shintaro Takaki; Hiroo Shirakawa; Soo-Cheol Jeong; Keitaro Yamashina; Akira Hiramatsu; Hideaki Kodama; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

6.  An atypical extrahepatic metastasis of the distal phalanx from hepatocellular carcinoma.

Authors:  Masaki Otsuji; Shunji Matsunaga; Hiroaki Koga; Naoya Kawabata; Takanori Imakiire; Takuya Hiwaki; Yukie Tashiro; Hiroshi Shirahama; Setsuro Komiya
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

7.  Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors.

Authors:  Jong-Bum Kwon; Khun Park; Young-Du Kim; Jong-Hee Seo; Seok-Whan Moon; Deog-Gon Cho; Yong-Whan Kim; Dong-Goo Kim; Seung-Kew Yoon; Hyeon-Woo Lim
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.